Viruses 2010, 2(2), 334-371; doi:10.3390/v2020334
Review

Development of Viral Vectors for Use in Cardiovascular Gene Therapy

email, email, email and * email
Received: 14 December 2009; in revised form: 15 January 2010 / Accepted: 26 January 2010 / Published: 27 January 2010
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Cardiovascular disease represents the most common cause of mortality in the developed world but, despite two decades of promising pre-clinical research and numerous clinical trials, cardiovascular gene transfer has so far failed to demonstrate convincing benefits in the clinical setting. In this review we discuss the various targets which may be suitable for cardiovascular gene therapy and the viral vectors which have to date shown the most potential for clinical use. We conclude with a summary of the current state of clinical cardiovascular gene therapy and the key trials which are ongoing.
Keywords: cardiovascular gene therapy; adenovirus; adeno-associated virus; lentivirus
PDF Full-text Download PDF Full-Text [348 KB, uploaded 27 January 2010 17:24 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Williams, P.D.; Ranjzad, P.; Kakar, S.J.; Kingston, P.A. Development of Viral Vectors for Use in Cardiovascular Gene Therapy. Viruses 2010, 2, 334-371.

AMA Style

Williams PD, Ranjzad P, Kakar SJ, Kingston PA. Development of Viral Vectors for Use in Cardiovascular Gene Therapy. Viruses. 2010; 2(2):334-371.

Chicago/Turabian Style

Williams, Paul D.; Ranjzad, Parisa; Kakar, Salik J.; Kingston, Paul A. 2010. "Development of Viral Vectors for Use in Cardiovascular Gene Therapy." Viruses 2, no. 2: 334-371.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert